Quinoxaline

Quinoxaline

SCHEMBL7039887

c1cc[nH]c1.c1ccc2nccnc2c1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPK1 P28482 1/20 0.41
▸ LOXL2 Q9Y4K0 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.38
▸ NCF1 P14598 1/20 0.38
▸ HTR1A P08908 2/20 0.38
▸ ADRA1D P25100 2/20 0.38
▸ ADRA1A P35348 2/20 0.38
▸ ADRA1B P35368 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CCNB2 O95067 3/20 0.36
▸ CDK1 P06493 3/20 0.36
▸ CCNB1 P14635 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoxaline SCHEMBL29027111 1.00 ALDH1A1 (0.44) ALDH1A1MAPK1LOXL2PDE10ANCF1
Quinoxaline SCHEMBL28317567 0.89 TSHR (0.38) ALDH1A1MAPK1LOXL2PDE10ANCF1
Quinoxaline SCHEMBL6928518 0.83 ALDH1A1 (0.58) ALDH1A1LOXL2PDE10ANCF1HTR1A
Quinoxaline SCHEMBL30320908 0.83 ALDH1A1 (0.58) ALDH1A1LOXL2PDE10ANCF1HTR1A
Quinoxaline SCHEMBL29355228 0.83 ALDH1A1 (0.58) ALDH1A1LOXL2PDE10ANCF1HTR1A
Quinoxaline SCHEMBL5315 0.83 ALDH1A1 (0.58) ALDH1A1LOXL2PDE10ANCF1HTR1A
Quinoline SCHEMBL5567268 0.81 ALDH1A1 (0.74) ALDH1A1PDE10ATSHRMAPTKDM4E
Quinoxaline SCHEMBL3647158 0.80 ALDH1A1 (0.55) ALDH1A1LOXL2PDE10ANCF1HTR1A
Quinoxaline SCHEMBL9171633 0.80 ALDH1A1 (0.55) ALDH1A1LOXL2PDE10ANCF1HTR1A
Quinoxaline SCHEMBL2359961 0.80 ALDH1A1 (0.55) ALDH1A1LOXL2PDE10ANCF1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110867603-B Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof 常州大学 2022-03-22 — — CN claimed
CN-110867603-A Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof 常州大学 2020-03-06 — — CN claimed
CN-108467392-A 2- (ω-dialkyl amino) amine alkyl-3-aryls and azole quinoxaline compounds and its preparation method and application 广西师范大学 2018-08-31 — — CN claimed
CN-103333171-B Synthetic method of pyrrole [1,2-a ] quinoxaline derivative NANJING TECH UNIVERSITY (CN) 2015-10-28 — — CN claimed
US-20030162960-A1 Colormetric sensor compositions and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-08-28 — — US claimed
US-6482949-B1 Colormetric sensor compositions and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-11-19 — — US claimed
CN-113328092-B Aqueous holozine secondary battery based on oxazine compounds with multiple oxidation states 常州大学 2022-04-26 — — CN disclosed
CN-110867603-B Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof 常州大学 2022-03-22 — — CN disclosed
CN-110867603-B Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof 常州大学 2022-03-22 — — CN disclosed
CN-113328092-A Aqueous all-organic secondary battery based on oxazine compounds with multiple oxidation states 常州大学 2021-08-31 — — CN disclosed
CN-110867603-A Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof 常州大学 2020-03-06 — — CN disclosed
CN-110867603-A Polypyrrole-quinoxaline-negative-electrode-based all-water-system mixed flow battery and preparation method thereof 常州大学 2020-03-06 — — CN disclosed
CN-108467392-A 2- (ω-dialkyl amino) amine alkyl-3-aryls and azole quinoxaline compounds and its preparation method and application 广西师范大学 2018-08-31 — — CN disclosed
CN-108467392-A 2- (ω-dialkyl amino) amine alkyl-3-aryls and azole quinoxaline compounds and its preparation method and application 广西师范大学 2018-08-31 — — CN disclosed
CN-108467392-A 2- (ω-dialkyl amino) amine alkyl-3-aryls and azole quinoxaline compounds and its preparation method and application 广西师范大学 2018-08-31 — — CN disclosed
CN-102858841-B Quinoxaline conjugated polymer containing fused ring thiophene unit and preparation method and application thereof OCEANS KING LIGHTING SCIENCE 2014-03-12 — — CN disclosed
CN-102858842-A Conjugated polymer containing dithienopyrrole-quinoxaline, preparation method and uses thereof OCEANS KING LIGHTING SCIENCE 2013-01-02 — — CN disclosed
US-20030162960-A1 Colormetric sensor compositions and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-08-28 — — US disclosed
US-6482949-B1 Colormetric sensor compositions and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162960-A1 Colormetric sensor compositions and methods PAH, NISCH, SPR ALDH1A1 1798/4885MAPK1 1306/4885LOXL2 4628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback